Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Dihydro-β-erythroidine hydrobromide | 29734-68-7 | MFCD00153793 | >98.0% | 356.26 g·mol⁻¹ | C16H21NO3·HBr | 1 MG
Supplier: Medchemexpress LLC HY1076701MG
Dihydro-β-erythroidine hydrobromide is a competitive antagonist of neuronal nicotinic acetylcholine receptors with preferential activity at α4-containing subtypes. It is used as a pharmacological tool in electrophysiology and behavioral studies to investigate nicotinic signaling and nicotine-related effects. Supplied as the hydrobromide salt, it is suitable for both in vitro and in vivo research applications.
- Selective, competitive antagonist of neuronal nAChRs.
- Shows selectivity for α4β2 and α4β4 receptor subtypes.
- Orally bioavailable and active in vivo.
- High purity (≥98%) suitable for research use.
- Provided as a stable hydrobromide salt for handling and formulation.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?